Tomorrow the English Shire will publish her past quarter's figures. Based on the analysts' estimates both the revenue and the net result would be the highest in years. For this year Shire 's revenue will be around 15,05 billion GBp. This is according to the average of the analysts' estimates. The expected revenue would be the highest in her history. This is hugely more than 2016's revenue of 11,4 billion GBp.
The analysts anticipate for 2017 a record net profit a 4,54 billion GBp. According to most of the analysts the company will have a profit per share for this book year of 498 GBp. The price/earnings-ratio therefore equals 8,55.
For this year the analysts expect a dividend of 38 GBp per share. Thus the dividend yield equals 0,89 percent. The average dividend yield of the pharmaceutical companies equals a moderate 1,33 percent.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.